Variable | potAVERT (n = 105) | AVERT (n = 50) | Effect size* (95% CI) | p | ||
---|---|---|---|---|---|---|
Age (years) | ||||||
Mean (±SD) | 73 | (±13.6) | 75 | (±12.6) | 2.25 (−1.18-5.60) | 0.17 |
Sex | ||||||
Female | 47 | (45%) | 23 | (46%) | 1.05 (0.54-2.06) | >0.99 |
Past medical history | ||||||
Hypertension | 64 | (61%) | 38 | (76%) | 2.03 (0.96-4.28) | 0.07 |
Diabetes | 21 | (20%) | 16 | (32%) | 1.88 (0.89-4.01) | 0.11 |
High cholesterol | 47 | (45%) | 23 | (46%) | 1.05 (0.54-2.06) | >0.99 |
Peripheral vascular disease | 4 | (3.8%) | 0 | 0 | 0 (0–2.00) | 0.31 |
Ischaemic heart disease | 22 | (21%) | 10 | (20%) | .94 (0.42-2.15) | >0.99 |
Angina | 6 | (5.7%) | 2 | (4.0%) | 0.69 (0–3.12) | >0.99 |
Arthritis (lower limb) | 6 | (5.7%) | 4 | (8.0%) | 1.42 (0.41-4.94) | 0.73 |
Lower limb joint replacement | 4 | (3.8%) | 2 | (4.0%) | 1.05 (0–5.12) | >0.99 |
Emphysema or COPD | 5 | (4.8%) | 1 | (2.0%) | 0.41 (0–2.74) | 0.67 |
Atrial fibrillation | 25 | (24%) | 14 | (28%) | 1.24 (0.59-2.65) | 0.69 |
Premorbid mRS | ||||||
Independent (mRS 0–2) | 105 | (100%) | 50 | (100%) | N/A | >0.99 |
NIHSS On admission | ||||||
Median (IQR) | 11 | (6–17) | 10.5 | (6–18) | 0 (−2-2) | 0.91 |
Oxfordshire | ||||||
TACI | 33 | (31%) | 24 | (48%) | ||
PACI | 48 | (46%) | 22 | (44%) | 0.09 | |
POCI | 7 | (6.7%) | 1 | (2.0%) | ||
LACI | 17 | (16%) | 3 | (6.0%) | ||
Imaging | ||||||
Large cortical | 56 | (53%) | 32 | (64%) | ||
Small cortical | 6 | (5.7%) | 1 | (2.0%) | ||
Hemispheric lacunar | 6 | (5.7%) | 3 | (6.0%) | ||
Brain stem | 6 | (5.7%) | 0 | 0 | 0.49 | |
Cerebellum | 1 | (1.0%) | 0 | 0 | ||
Hemispheric non cortical | 12 | (11%) | 4 | (8.0%) | ||
Other | 1 | (1.0%) | 0 | 0 |